BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21435335)

  • 1. Blood-arachnoid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging.
    Ichikawa H; Itoh K
    Brain Res; 2011 May; 1390():142-9. PubMed ID: 21435335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of blood-cerebrospinal fluid barrier permeability in the rat with experimental meningitis using magnetic resonance imaging.
    Ichikawa H; Ishikawa M; Fukunaga M; Ishikawa K; Ishiyama H
    Brain Res; 2010 Mar; 1321():125-32. PubMed ID: 20114032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
    Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
    Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
    Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
    Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis.
    Barichello T; Pereira JS; Savi GD; Generoso JS; Cipriano AL; Silvestre C; Petronilho F; Dal-Pizzol F; Vilela MC; Teixeira AL
    J Neuroimmunol; 2011 Apr; 233(1-2):12-7. PubMed ID: 21109308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging.
    Brandt CT; Simonsen H; Liptrot M; Søgaard LV; Lundgren JD; Ostergaard C; Frimodt-Møller N; Rowland IJ
    BMC Med Imaging; 2008 Jan; 8():1. PubMed ID: 18194516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches.
    Sharma HS; Johanson CE
    Ann N Y Acad Sci; 2007 Dec; 1122():112-29. PubMed ID: 18077568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia.
    Strbian D; Durukan A; Pitkonen M; Marinkovic I; Tatlisumak E; Pedrono E; Abo-Ramadan U; Tatlisumak T
    Neuroscience; 2008 Apr; 153(1):175-81. PubMed ID: 18367342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.
    Nakamura M; Yamashita T; Ueda M; Obayashi K; Sato T; Ikeda T; Washimi Y; Hirai T; Kuwahara Y; Yamamoto MT; Uchino M; Ando Y
    Neurology; 2005 Oct; 65(7):1051-6. PubMed ID: 16217058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular permeability changes during experimental meningitis in the rat.
    Boje KM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1199-203. PubMed ID: 7562488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-ischemic blood-brain barrier leakage in rats: one-week follow-up by MRI.
    Durukan A; Marinkovic I; Strbian D; Pitkonen M; Pedrono E; Soinne L; Abo-Ramadan U; Tatlisumak T
    Brain Res; 2009 Jul; 1280():158-65. PubMed ID: 19450568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis.
    Boje KM
    Brain Res; 1996 May; 720(1-2):75-83. PubMed ID: 8782899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging.
    Liu HL; Wai YY; Chen WS; Chen JC; Hsu PH; Wu XY; Huang WC; Yen TC; Wang JJ
    Ultrasound Med Biol; 2008 Apr; 34(4):598-606. PubMed ID: 18313204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new method for measuring blood-brain barrier permeability demonstrated with Europium-bound albumin during experimental lipopolysaccharide (LPS) induced meningitis in the rat.
    Ivey NS; Martin EN; Scheld WM; Nathan BR
    J Neurosci Methods; 2005 Mar; 142(1):91-5. PubMed ID: 15652621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of Gd-DTPA on magnetic resonance imaging: a potential blood-brain barrier indicator].
    Hashimoto K; Yamagata S; Minamikawa J; Watanabe Y; Kanesiro M; Kikuchi H
    No To Shinkei; 1988 May; 40(5):461-6. PubMed ID: 3415864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of BBB disruption and hemorrhage by Gd-DTPA enhanced MRI after embolic stroke in rat.
    Ding G; Jiang Q; Li L; Zhang L; Gang Zhang Z; Ledbetter KA; Ewing JR; Li Q; Chopp M
    Brain Res; 2006 Oct; 1114(1):195-203. PubMed ID: 16950236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.
    Uchida Y; Sumiya T; Tachikawa M; Yamakawa T; Murata S; Yagi Y; Sato K; Stephan A; Ito K; Ohtsuki S; Couraud PO; Suzuki T; Terasaki T
    Mol Neurobiol; 2019 Mar; 56(3):2039-2056. PubMed ID: 29984400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammatory role of prostaglandins during experimental meningitis: evidence suggestive of an in vivo relationship between nitric oxide and prostaglandins.
    Boje KM; Jaworowicz D; Raybon JJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):319-25. PubMed ID: 12490607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice.
    Klohs J; Steinbrink J; Bourayou R; Mueller S; Cordell R; Licha K; Schirner M; Dirnagl U; Lindauer U; Wunder A
    J Neurosci Methods; 2009 May; 180(1):126-32. PubMed ID: 19427539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
    Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.